Liz Morrell
Overview
Explore the profile of Liz Morrell including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
17
Citations
114
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Mawalla Dr W, Achola C, Nabalende H, Otim I, Legason I, Ogwang M, et al.
Blood Adv
. 2025 Feb;
PMID: 39983056
The addition of rituximab to the chemotherapy backbone was shown to significantly improve outcomes of children with aggressive high-grade lymphomas in high-income countries. However, data on its safety, and efficacy...
2.
Roope L, Morrell L, Buchanan J, Ledda A, Adler A, Jit M, et al.
Commun Med (Lond)
. 2024 May;
4(1):101.
PMID: 38796507
Bacteria are becoming increasingly resistant to antibiotics, reducing our ability to treat infections and threatening to undermine modern health care. Optimising antibiotic use is a key element in tackling the...
3.
Charlton V, DiStefano M, Mitchell P, Morrell L, Rand L, Badano G, et al.
Health Econ Policy Law
. 2023 Sep;
19(2):153-173.
PMID: 37752732
It is acknowledged that health technology assessment (HTA) is an inherently value-based activity that makes use of normative reasoning alongside empirical evidence. But the language used to conceptualise and articulate...
4.
Mawalla W, Morrell L, Chirande L, Achola C, Mwamtemi H, Sandi G, et al.
Blood Adv
. 2023 May;
7(17):4962-4965.
PMID: 37171463
No abstract available.
5.
Tonkin-Crine S, Mcleod M, Borek A, Campbell A, Anyanwu P, Costelloe C, et al.
Br J Gen Pract
. 2023 Feb;
73(728):e164-e175.
PMID: 36823061
Background: Trials have identified antimicrobial stewardship (AMS) strategies that effectively reduce antibiotic use in primary care. However, many are not commonly used in England. The authors co-developed an implementation intervention...
6.
Borek A, Maitland K, Mcleod M, Campbell A, Hayhoe B, Butler C, et al.
Antibiotics (Basel)
. 2021 Dec;
10(12).
PMID: 34943743
The COVID-19 pandemic has had a profound impact on the delivery of primary care services. We aimed to identify general practitioners' (GPs') perceptions and experiences of how the COVID-19 pandemic...
7.
Morrell L, Buchanan J, Roope L, Pouwels K, Butler C, Hayhoe B, et al.
PLoS Med
. 2021 Aug;
18(8):e1003737.
PMID: 34460825
Background: Delayed (or "backup") antibiotic prescription, where the patient is given a prescription but advised to delay initiating antibiotics, has been shown to be effective in reducing antibiotic use in...
8.
Morrell L, Buchanan J, Rees S, Barker R, Wordsworth S
Pharmacoeconomics
. 2021 Aug;
39(12):1443-1454.
PMID: 34409564
Background: Decisions on funding new healthcare technologies assume that all health improvements are valued equally. However, public reaction to health technology assessment (HTA) decisions suggests there are health attributes that...
9.
Buchanan J, Roope L, Morrell L, Pouwels K, Robotham J, Abel L, et al.
Appl Health Econ Health Policy
. 2021 Mar;
19(4):521-535.
PMID: 33682065
Background: In the UK, consultations for prescription medicines are available via private providers such as online pharmacies. However, these providers may have lower thresholds for prescribing certain drugs. This is...
10.
Pouwels K, Roope L, Buchanan J, Morrell L, Tonkin-Crine S, Peters M, et al.
Antibiotics (Basel)
. 2020 Oct;
9(10).
PMID: 33066092
Influenza-like illnesses (ILI) account for a significant portion of inappropriate antibiotic use. Patient expectations for antibiotics for ILI are likely to play a substantial role in 'unnecessary' antibiotic consumption. This...